Drs Pringl Miller, Preeti John, and Sabha Ganai join Ethics Talk to discuss their article: “How Should Surgical Palliative Success Be Defined?”

If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.

Many devices in current use were marketed before manufacturers were required to demonstrate safety and effectiveness.

Differentiating between best palliative care options and the curative and palliative potential of surgery is key to developing dual intentional clarity.

A surgeon’s duty is to identify goals of care, including those about quality of life, from a patient’s perspective and to consider how to achieve them.

Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"

Both physicians and pharmacists have responsibilities to ensure that opioids are prescribed and dispensed for legitimate medical purposes and to meet legal requirements.

Whether a patient’s decisional regret constitutes a failure of shared decision making can depend on how a decision was made.

Shared decision making honors patient autonomy, particularly for preference-sensitive care decisions and even when patients have impaired decision-making capacity.

Enhanced Recovery After Surgery (ERAS®) protocols vary by surgery type and are compared, clinically and ethically, to traditional protocols.